Stocks360

Caliber Imaging & Diagnostics, Inc. (LCDX)

Stock analysis · OTC · Healthcare · Medical - Devices

Share: Facebook X WhatsApp SMS

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
N/A
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
0.46
Day Range
N/A
52-wk Range
N/A
Avg Volume
N/A
Volume
N/A

Caliber Imaging & Diagnostics, Inc. (LCDX) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 4 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

Proprietary Signals

Signal snapshot temporarily unavailable.

About Caliber Imaging & Diagnostics, Inc.

Caliber Imaging & Diagnostics, Inc. is a U.S.-based medical technology firm that develops, manufactures, and markets advanced imaging solutions designed to visualize tissue at a cellular resolution. Their product line features the VivaScope 1500, a reflectance confocal imaging system that empowers medical practitioners and scientists to capture detailed confocal images depicting the cellular architecture of living tissue. They also provide the VivaScope 3000, a handheld in vivo reflectance confocal microscope tailored for dermatological imaging. Complementing its hardware, the firm offers VivaScan software, which streamlines patient scheduling, facilitates multi-lesion imaging during appointments, and assists with image review and reporting. Additionally, they supply VivaNet, a sophisticated digital telepathology system. Initially established as Lucid, Inc. in 1991, the company rebranded as Caliber Imaging & Diagnostics, Inc. in August 2012 and is headquartered in Andover, Massachusetts.

Valuation

Trailing twelve months. Multiples relative to current market price.
EV / EBITDA-2.35×
EV / Sales3.29×
Earnings Yield-108913.57%
Free Cash Flow Yield-95314.11%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value$11.00M
Revenue (TTM)$3.34M
Net Income (TTM)-$5.56M
Free Cash Flow (TTM)-$4.10M
Net Debt$10.99M
Working Capital-$5.12M
Return on Equity54.25%
Return on Invested Capital-23894.30%

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap